AC
ATIP

Apogem Capital’s ATI Physical Therapy, Inc. ATIP Stock Holding History

Apogem Capital’s Portfolio ATIP Stock Details ATIP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-264
Closed -$126K – 229
2021
Q2 		$126K Buy
+264
New +$131K 0.08% 176

Other funds holding ATIP

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
FIG
Fortress Investment Group New York $394M AUM 22.99% 1-Year Est. Return
GH
Grosvenor Holdings Chicago, Illinois $512M AUM 19.57% 1-Year Est. Return
KCM
Knighthead Capital Management New York $1.52B AUM 19.8% 1-Year Est. Return
BCA
Bernzott Capital Advisors Camarillo, California $250M AUM 26.89% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $10.5B AUM 49.21% 1-Year Est. Return
MAC
Monarch Alternative Capital New York $1.63B AUM 125.01% 1-Year Est. Return
LCM
Lakewood Capital Management New York $1.58B AUM 0.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Apogem Capital's ATIP Position: Q3 2021 in Review

Apogem Capital sold out of ATI Physical Therapy, Inc. (ATIP) in Q3 2021, closing a stake of 264 shares — an estimated $126K sold.

Apogem Capital first reported a position in ATIP in Q2 2021 and held it in 1 quarter. The position peaked at $126K in Q2 2021. 79 funds tracked by Wall St. Rank hold ATIP as of Q3 2021.

  • Apogem Capital reported no remaining ATI Physical Therapy, Inc. position as of Q3 2021 after selling out during the quarter.
  • Apogem Capital sold 264 ATI Physical Therapy, Inc. shares in Q3 2021, an estimated $126K.
  • Apogem Capital first reported a position in ATI Physical Therapy, Inc. in Q2 2021 and held it in 1 quarter.
  • Apogem Capital's ATI Physical Therapy, Inc. position peaked at $126K in Q2 2021.
  • 79 funds tracked by Wall St. Rank held ATI Physical Therapy, Inc. as of Q3 2021.

Based on Apogem Capital's 13F filing for Q3 2021, filed 15 Nov 2021.